BackTelomir Pharmaceuticals Overview

Telomir Pharmaceuticals Total Liabilities

Track Telomir Pharmaceuticals's total liabilities ($330K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$332424.00
↓ 4.58% YoYΔ $-15964.00 vs prior year quarter

Peer trimmed avg / median

Loading

Telomir Pharmaceuticals Total Liabilities History

Loading

Telomir Pharmaceuticals vs. peers: Total Liabilities Comparison

Loading

Telomir Pharmaceuticals Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Telomir Pharmaceuticals (TELO) FAQ

As of the most recent data (June 2026), TELO shows a total liabilities of $330K. That compares with $350K in the prior-year period — down 4.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, TELO's total liabilities is now $330K (was $350K) — a 4.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Telomir Pharmaceuticals is outperforming or lagging.

Tracking TELO's total liabilities over time shows whether Telomir Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $330K That compares with $350K in the prior-year period — down 4.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Telomir Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $330K) with ownership activity and broader fundamentals.